News

For the first time ever, neurophysiologists have succeeded in reversibly disabling a connection between two areas in the brains of primates while they were performing cognitive tasks.

Until recently, scientists did not have tools to systematically characterise specific walking deficits in different mouse models of neurological conditions. To solve this problem, Megan Carey's lab, at the Champalimaud Centre for the Unknown in Portugal, developed LocoMouse: an automated movement-tracking system that captures the fine details of locomotion in mice.

A fault in the RNA quality control system of cells leads to the haywire production of toxic proteins in ALS, according to a new study.

Researchers have found that they can differentiate between subtypes of dementia inducing brain disease, defining a new form of dementia along the way.

Research has examined a possible new therapeutic approach for Alzheimer's disease that targets inflammation by using an antibody.

A new study took a look at one particular medication for the treatment of anxiety disorders in pediatric patients to see if it was beneficial.

SARS-CoV-2 can infect human neural progenitor cells and brain organoids, as shown by researchers from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences and their collaborators from The University of Hong Kong (HKU).

A new study has explored safety and early outcomes in a large cohort of SMA patients under the age of two years who were treated with gene therapy.

A collaborative team of researchers from the University of Toronto Engineering and the University of Michigan have redesigned a naturally occurring enzyme that has demonstrated the ability to promote nerve regrowth in nerve damage models, increasing its activity and stability.

A new study suggests that internet searches related to panic attacks reached record highs duing the COVID-19 pandemic, highlighting a novel way of estimating the mental health impacts caused by the pandemic.